Vanguard Group Inc Armata Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 260,073 shares of ARMP stock, worth $618,973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260,073
Previous 234,119
11.09%
Holding current value
$618,973
Previous $433,000
12.47%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ARMP
# of Institutions
30Shares Held
770KCall Options Held
300Put Options Held
1K-
Geode Capital Management, LLC Boston, MA106KShares$251,8920.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$238,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$106,3430.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$95,9140.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny38.6KShares$91,8580.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $86M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...